
Artificial intelligence (AI)-first drug discovery startup Isomorphic Labs announced on Tuesday that it has raised $2.1 billion in a Series B funding round led by Thrive Capital.
The round also saw participation from existing investors Alphabet and venture capital (VC) firm GV (formerly known as Google Ventures).